Insider Shareholders with Direct Ownership of Phathom Pharmaceuticals, Inc. (PHAT)
This section provides a comprehensive overview of the insiders with direct ownership of Phathom Pharmaceuticals, Inc. (PHAT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Phathom Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Takeda Pharmaceutical Co Ltd
> 10% Shareholder |
7,588,000 | 4,916,417 | 3,755,583 $31.2 Million | 38 |
Jan 24, 2024
Reduced 49.65%
|
|
Terrie Curran
President and Chief Executive |
440,682 | 90,104 | 360,465 $3 Million | 16 |
Jan 21, 2025
Reduced 5.03%
|
|
Azmi Nabulsi
Chief Operating Officer |
323,200 | 887,105 | 312,590 $2.6 Million | 13 |
Feb 27, 2025
Added 20.21%
|
| 113,500 | 0 | 113,500 $944,320 | 16 |
Jun 03, 2025
Added 8.47%
|
|
|
Molly Henderson
CFO and CBO |
205,500 | 51,938 | 89,868 $747,701 | 22 |
Apr 07, 2025
Reduced 3.93%
|
| 67,500 | 0 | 67,500 $561,600 | 5 |
Jun 03, 2025
Added 13.46%
|
|
|
Robert Charles Breedlove
Principal Accounting Officer |
0 | 1,692 | 48,392 $402,621 | 1 |
Jul 16, 2025
Reduced 3.38%
|
| 30,000 | 0 | 42,596 $354,398 | 3 |
Jun 03, 2025
Added 19.78%
|
|
| 39,798 | 0 | 39,798 $331,119 | 4 |
Jun 03, 2025
Added 20.88%
|
|
| 30,000 | 0 | 30,000 $249,600 | 3 |
Jun 03, 2025
Added 25.93%
|
|
| 30,000 | 0 | 30,000 $249,600 | 3 |
Jun 03, 2025
Added 25.93%
|
|
| 21,000 | 0 | 21,000 $174,720 | 1 |
Apr 16, 2025
Added 50.0%
|
|
| 19,500 | 0 | 19,500 $162,240 | 2 |
May 23, 2024
Added 35.0%
|
|
|
Anthony J. Guzzo
VP, Chief Accounting Officer |
6,000 | 0 | 8,399 $69,879 | 1 |
Jan 19, 2022
Added 41.67%
|